IL111176A0 - Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them - Google Patents

Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them

Info

Publication number
IL111176A0
IL111176A0 IL11117694A IL11117694A IL111176A0 IL 111176 A0 IL111176 A0 IL 111176A0 IL 11117694 A IL11117694 A IL 11117694A IL 11117694 A IL11117694 A IL 11117694A IL 111176 A0 IL111176 A0 IL 111176A0
Authority
IL
Israel
Prior art keywords
trypsin
enzymes
pharmaceutical compositions
compositions containing
boronic acid
Prior art date
Application number
IL11117694A
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/139,444 external-priority patent/US5462964A/en
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of IL111176A0 publication Critical patent/IL111176A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11117694A 1993-10-07 1994-10-05 Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them IL111176A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13325293A 1993-10-07 1993-10-07
US08/139,444 US5462964A (en) 1993-10-20 1993-10-20 Dipeptide boronic acid inhibitors of trypsin-like enzymes

Publications (1)

Publication Number Publication Date
IL111176A0 true IL111176A0 (en) 1994-12-29

Family

ID=26831205

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11117694A IL111176A0 (en) 1993-10-07 1994-10-05 Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them

Country Status (3)

Country Link
AU (1) AU7922694A (en)
IL (1) IL111176A0 (en)
WO (1) WO1995009858A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5693617A (en) * 1994-03-15 1997-12-02 Proscript, Inc. Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US20050288253A1 (en) 2002-09-09 2005-12-29 Trigen Limited Boronic acid salts
EP1396270B1 (en) * 2002-09-09 2006-05-10 Trigen Limited Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis
CA2508290C (en) 2002-12-20 2017-02-28 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
US7378426B2 (en) 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7417040B2 (en) 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
GB0505969D0 (en) 2005-03-23 2005-04-27 Novartis Ag Organic compounds
EP1968940B1 (en) 2005-12-30 2014-04-02 Novartis AG 3 , 5-substitued piperidine compounds as renin inhibitors
NZ582098A (en) 2007-06-25 2012-03-30 Novartis Ag N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
WO2017222914A1 (en) 2016-06-21 2017-12-28 Inception 4, Inc. Carbocyclic prolinamide derivatives
CN109476637B (en) 2016-06-21 2022-02-01 奥瑞恩眼科有限责任公司 Heterocyclic prolinamide derivatives
MX2022015207A (en) 2020-06-10 2023-02-13 Aligos Therapeutics Inc Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections.
KR20240035513A (en) 2021-07-09 2024-03-15 알리고스 테라퓨틱스 인코포레이티드 antiviral compounds
US12065428B2 (en) 2021-09-17 2024-08-20 Aligos Therapeutics, Inc. Anti-viral compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
GB9024129D0 (en) * 1990-11-06 1990-12-19 Thrombosis Research Trust Inhibitors and substrates of thrombin
EP0503203A1 (en) * 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors

Also Published As

Publication number Publication date
WO1995009858A1 (en) 1995-04-13
AU7922694A (en) 1995-05-01

Similar Documents

Publication Publication Date Title
IL111176A0 (en) Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them
IL86613A0 (en) Peptide boronic acid derivatives and compositions containing them for inhibiting trypsin-like proteases
IL111175A0 (en) Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
ZA9510978B (en) Boronic acid and ester inhibitors of thrombin
HUP9900964A3 (en) Protease inhibitors and pharmaceutical compositions containing these compounds
HUP9702036A3 (en) Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them
HUP9702035A3 (en) Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them
IL109503A0 (en) Hiv protease inhibitors and pharmaceutical compositions containing them
HUP9702034A3 (en) Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them
HUP0001796A3 (en) Dipeptide benzamidine as a kininogenase inhibitor and pharmaceutical compositions containing them
IL109867A0 (en) alpha-heteroaryloxymethyl ketones as interleukin -1beta protease inhibitors and pharmaceutical compositions containing them
FI965036A7 (en) Interleukin-beta converting enzyme inhibitors and pharmaceutical compositions containing them
IL89900A0 (en) Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
IL96691A0 (en) Hiv protease inhibitors and pharmaceutical compositions containing them
AU3967195A (en) Amidino and guanidino substituted inhibitors of trypsin-like enzymes
IL84945A (en) Renin inhibiting peptidyl aminodiols and pharmaceutical compositions comprising them
IL91307A0 (en) Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them
HUP9902105A3 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
IL119466A0 (en) Thrombin inhibitors their preparation and pharmaceutical compositions containing them
HUP0002951A3 (en) Bis-aminomethylcarbonyl compounds as protease inhibitors and pharmaceutical compositions containing them
IL120311A0 (en) Serine protease inhibitors and pharmaceutical compositions containing them
IL120310A0 (en) Serine protease inhibitors and pharmaceutical compositions containing them
AU6703894A (en) Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
IL110724A (en) Retroviral protease inhibitors and pharmaceutical compositions containing them
NZ237185A (en) Hiv protease inhibitors containing amino acid units and pharmaceutical compositions thereof